IGMS

1.71

3.39% -0.06

Pre-mercato: 1.76 0.05 +2.92%

Igm Biosciences Inc (IGMS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.77

Aprire:

$1.78

Volume 24 ore:

700.77K

Relative Volume:

1.75

Capitalizzazione di mercato:

$101.68M

Reddito:

$2.91M

Utile/perdita netta:

$-220.40M

Rapporto P/E:

-0.4698

EPS:

-3.64

Flusso di cassa netto:

$-176.15M

1 W Prestazione:

+0.00%

1M Prestazione:

-75.22%

6M Prestazione:

-84.08%

1 anno Prestazione:

-83.75%

Intervallo 1D:

$1.62

$1.80

Intervallo di 1 settimana:

$1.59

$2.06

Portata 52W:

$1.59

$22.50

Igm Biosciences Inc Stock (IGMS) Company Profile

Nome

Igm Biosciences Inc

Settore

Healthcare (1176)

Industria

Biotechnology (685)

Telefono

650-965-7873

Indirizzo

325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW

Dipendente

198

Cinguettio

Prossima data di guadagno

2024-11-11

Ultimi documenti SEC

IGMS's Discussions on Twitter

Confronta IGMS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IGMS Igm Biosciences Inc	1.71	101.68M	2.91M	-220.40M	-176.15M	-3.64
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-10	Downgrade	BMO Capital Markets	Outperform → Market Perform
2025-01-10	Downgrade	Guggenheim	Buy → Neutral
2025-01-10	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2025-01-10	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2025-01-10	Downgrade	Stifel	Buy → Hold
2024-12-06	Iniziato	BMO Capital Markets	Outperform
2024-10-01	Downgrade	JP Morgan	Neutral → Underweight
2024-10-01	Downgrade	Truist	Buy → Hold
2024-02-09	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2023-12-15	Downgrade	BofA Securities	Buy → Neutral
2023-12-07	Downgrade	H.C. Wainwright	Buy → Neutral
2022-11-09	Ripresa	Jefferies	Buy
2022-10-17	Iniziato	JP Morgan	Neutral
2022-08-29	Iniziato	BofA Securities	Buy
2021-12-13	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2021-11-05	Aggiornamento	Wedbush	Neutral → Outperform
2021-08-26	Iniziato	Morgan Stanley	Overweight
2021-01-29	Iniziato	RBC Capital Mkts	Outperform
2021-01-19	Reiterato	H.C. Wainwright	Buy
2020-12-22	Downgrade	Wedbush	Outperform → Neutral
2020-07-17	Iniziato	Robert W. Baird	Outperform
2020-07-01	Iniziato	H.C. Wainwright	Buy
2020-05-28	Iniziato	SunTrust	Buy
2020-04-22	Iniziato	Wedbush	Outperform
2019-10-14	Iniziato	Guggenheim	Buy
2019-10-14	Iniziato	Jefferies	Buy
2019-10-14	Iniziato	Piper Jaffray	Overweight
2019-10-14	Iniziato	Stifel	Buy